The Frequency of Routine Blood Sampling and Patient Outcomes Among Maintenance Hemodialysis Recipients
ConclusionsMonthly routine blood testing in HD recipients was not associated with a lower risk for death, cardiovascular events, or hospitalizations as compared with testing every 6 weeks. Given the health resource implications, the frequency of routine blood sampling in HD recipients deserves careful reassessment.
Publication date: Available online 10 October 2020Source: American Journal of Kidney DiseasesAuthor(s): Ibironke W. Apata, Sarah Kabbani, Alicia M. Neu, Tamara M. Kear, Erika M.C. D’Agata, David J. Levenson, Alan S. Kliger, Lauri A. Hicks, Priti R. Patel, authors constitute the ASN and CDC Antibiotic Stewardship White Paper Writing Group
Publication date: Available online 9 October 2020Source: Clinical Lymphoma Myeloma and LeukemiaAuthor(s): Hajime Yasuda, Yutaka Tsukune, Tadaaki Inano, Yosuke Mori, Yasunori Ota, Norio Komatsu
CONCLUSIONS: NA to HD regimens is common amongst patients in Cameroon. Younger age and being unmarried were the predictors of NA to fluid restriction. PMID: 33028122 [PubMed - in process]
Condition: Hemodialysis Interventions: Drug: Ramipril; Drug: placebo Sponsor: Ain Shams University Completed
Rationale: Metformin-associated lactic acidosis (MALA) is a rare adverse effect that has significant morbidity and mortality. MALA is a high anion gap (AG), nonosmolar acidosis. Associated osmolar-gap (OG) is rarely reported, so finding an OG may make the diagnosis of MALA challenging. Patient concerns: Forty-five years’ old type II diabetic patient on metformin presented to emergency with a two-day history of vomiting, watery diarrhea, and mild abdominal discomfort. On examinations, he looked dehydrated. Investigation revealed acute kidney injury (AKI) with a high lactic acid (LA) level of 24 mmol/L, pH of 6....
Authors: Baek SD, Jeung S, Go J, Kang JY Abstract OBJECTIVES: The aim of this study was to investigate whether blood temperature monitoring-guided vascular access intervention could improve dialysis adequacy. METHODS: We retrospectively evaluated all patients who received outpatient-based prevalent hemodialysis patients (n = 84) in our artificial kidney room between January 2019 and October 2019. Through blood temperature monitoring, access blood flow was calculated every month and Kt/V was calculated every 3 months. The reference point was set at the time of vascular intervention in the pa...
Hydroxychloroquine (HQ) has been used for the treatment of novel coronavirus disease (COVID-19) even though there is no clear evidence for its effectiveness yet. In contrary, HQ has major side effects like QTc prolongation and subsequent development of ventricular arrhythmias. Such side effects may possess additional risks on end-stage renal disease (ESRD) patients who have higher cardiovascular risks than general population. We herein present 2 cases of sudden cardiac death in 2 ESRD patients with COVID-19 for whom a treatment regimen including HQ was preferred. Both patients were clinically stable at the time of arrest. ...
We report the first case of long-term ibrutinib administration in a hemodialysis patient with leukemic non-nodal mantle cell lymphoma (L-NN-MCL) in which ibr utinib therapy was both safe and effective.
Authors: Zhu F, Guo X, Liu H PMID: 33021365 [PubMed - as supplied by publisher]
What do we really know about the long-term safety of citrate-based dialysate and the potential impacts on outcomes in hemodialysis patients?Nephrology Dialysis Transplantation